Company Overview
About Signatur Biosciences
Signatur Biosciences is a London-based diagnostics company developing simple PCR-based tests that can detect complex diseases like breast cancer and other conditions using standard qPCR machines already present in most clinical laboratories — making sophisticated molecular diagnostics as accessible and operationally simple as a COVID-19 PCR test. Founded in 2022 and a Y Combinator S22 graduate, Signatur raised $7 million in May 2025 to scale its affordable, point-of-care compatible diagnostic solutions that address critical accessibility gaps in cancer diagnostics.
Business Model & Competitive Advantage
Signatur's smart PCR kit approach addresses a fundamental barrier in precision diagnostics: the most sensitive cancer detection tests (liquid biopsy, next-generation sequencing) require specialized expensive equipment and expert bioinformatics analysis that limits their use to major cancer centers. Signatur's tests use standard qPCR machines (which exist in regional hospitals, clinical labs, and diagnostic centers worldwide) and proprietary assay design that extracts equivalent diagnostic information from simpler equipment — democratizing access to early cancer detection beyond specialized oncology centers.
Competitive Landscape 2025–2026
In 2025, Signatur Biosciences competes in the molecular diagnostics and liquid biopsy market with Exact Sciences (Cologuard, Nasdaq: EXAS), Grail (Galleri multi-cancer early detection, Illumina), Foundation Medicine (Roche), and Guardant Health (GUARD) for cancer early detection and molecular diagnostics. The liquid biopsy and multi-cancer early detection space has attracted significant investment — Grail's Galleri test (which screens for 50+ cancers from a blood draw) represents the aspiration of the field but requires specialized sequencing infrastructure at $949 per test. Signatur's PCR-based approach could achieve widespread adoption if it delivers comparable clinical sensitivity on accessible equipment. The $7M May 2025 raise provides the runway to complete clinical validation studies. The 2025 strategy focuses on breast cancer as the lead indication, building the clinical evidence base for regulatory submission, and establishing NHS and international diagnostic laboratory partnerships.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Signatur Biosciences is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Compare Signatur Biosciences with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Signatur Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Signatur Biosciences Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Signatur Biosciences vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →